Checked elsewhere / Vera Files

“Ang clinical trial na kinasasangkutan ng 10,025 bata na may edad 2 hanggang 14 na taong gulang, ay nagpahiwatig ng "napakababang" 56% na efficacy rate para sa Dengvaxia vaccine.”
Dr. Erwin Erfe Claim dated 14 Jul 2022.
Vera Files rated thisNangangailangan ng konteksto

What Vera Files found

Noong Hulyo 14, iniutos ng World Health Organization (WHO) na ang mga bakuna ay kailangang magkaroon ng “high efficacy rate na 50% o mas mataas.” Binanggit ng WHO na ang Dengvaxia ay may efficacy rate na humigit-kumulang 80% sa mga bata na nasa edad na 9 hanggang 16 taong gulang na may dating dengue infection.

Their words, from the summary they publish with the rating.

In short

Dr. Erwin Erfe made this claim around 14 July 2022. Vera Files (Philippines) looked into it and published its finding on 4 August 2022, 21 days later. Its rating was “Nangangailangan ng konteksto”.

Where the claim appeared

Links recorded by Vera Files. Some posts may have been deleted since.

This check was done by Vera Files, not by DoesItStand. We list it so you can find it. Their full evidence and reasoning are in their article.